Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study

被引：2
|
作者：
Ahn, Myung-Ju [1 ]
Lim, Sung Hee [1 ]
Sun, Jong -Mu [1 ]
Choi, Yoon-La [1 ]
Kim, Hye Ryun [2 ]
Ahn, Soo-min [1 ]
Lee, Se-Hoon [1 ]
Ahn, Jin Seok [1 ]
Park, Keunchil [1 ]
Kim, Joo Hang [2 ]
Cho, Byoung Chul [2 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
[2] Yunsei Univ, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.jtho.2015.12.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Dovitinib in Pretreated Patients With Advanced Squamous Non-Small Cell Lung Cancer With FGFR1 Amplification: A Single-Arm, Phase 2 Study
    Lim, Sung Hee
    Sun, Jong-Mu
    Choi, Yoon-La
    Kim, Hye Ryun
    Ahn, Soomin
    Lee, Ji Yun
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Kim, Joo Hang
    Cho, Byoung Chul
    Ahn, Myung-Ju
    CANCER, 2016, 122 (19) : 3024 - 3031
  • [2] Efficacy and Safety of Dovitinib in Advanced Squamous Cell Lung Cancer with FGFR1 Amplification: A Single-Arm, Phase II Study
    Lim, Sung Hee
    Kim, Hye Ryun
    Kwak, Mikyong
    Han, Mijung
    Lee, Se-Hoon
    Sun, Jong-Mu
    Cho, Byoung Chul
    Ahn, Jin Seok
    Park, Keunchil
    Kim, Joo-Hang
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S375 - S375
  • [3] Fgfr1 Amplification In Squamous Cell Lung Cancer
    Gadgeel, S.
    Bepler, G.
    Schwartz, A.
    Land, S.
    Bollig-Fischer, A.
    Murphy, V.
    Cote, M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S221 - S222
  • [4] Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China
    Han, Xiao
    Guo, Jun
    Tang, Xiaoyong
    Zhu, Hui
    Zhu, Dongyuan
    Zhang, Xiqin
    Meng, Xiangjiao
    Hua, Ying
    Wang, Zhongtang
    Zhang, Yan
    Huang, Wei
    Wang, Linlin
    Yuan, Shuanghu
    Zhang, Pingliang
    Gong, Heyi
    Sun, Yulan
    Zhang, Yingjie
    Liu, Zengjun
    Wang, Zhehai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) : 1443 - 1451
  • [5] Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China
    Xiao Han
    Jun Guo
    Xiaoyong Tang
    Hui Zhu
    Dongyuan Zhu
    Xiqin Zhang
    Xiangjiao Meng
    Ying Hua
    Zhongtang Wang
    Yan Zhang
    Wei Huang
    Linlin Wang
    Shuanghu Yuan
    Pingliang Zhang
    Heyi Gong
    Yulan Sun
    Yingjie Zhang
    Zengjun Liu
    Zhehai Wang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1443 - 1451
  • [6] Novel predictor of FGFR1 inhibition efficacy in non-small cell lung cancer
    Quintanal-Villalonga, Alvaro
    Ferrer, Irene
    Marrugal, Angela
    Ojeda-Marquez, Laura
    Zugazagoita, Jon
    Garcia-Redondo, Laura
    Lopez-Rios, Fernando
    Montuenga, Luis
    Molina-Pinelo, Sonia
    Molina-Pinelo, Sonia
    Carnero, Amancio
    Paz-Ares, Luis
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Efficacy and safety of DCVAC/LuCa Treatment plus standard chemotherapy and TCM in patients with advanced non-small cell lung cancer: A single-arm phase II study.
    Lou, Yanni
    Jia, Liqun
    Liu, Qing
    Li, Liya
    Cui, Huijuan
    Deng, Chao
    Liu, Meng
    Su, Fei
    Cheng, Zhiqiang
    Wan, Donggui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
    Dutt, Amit
    Ramos, Alex H.
    Hammerman, Peter S.
    Mermel, Craig
    Cho, Jeonghee
    Sharifnia, Tanaz
    Chande, Ajit
    Tanaka, Kumiko Elisa
    Stransky, Nicolas
    Greulich, Heidi
    Gray, Nathanael S.
    Meyerson, Matthew
    PLOS ONE, 2011, 6 (06):
  • [9] Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study
    Shinoda, Masahiro
    Shinkai, Masaharu
    Hara, Yu
    Tomaru, Kouji
    Manabe, Saki
    Murakami, Syuji
    Saito, Haruhiro
    Kobayashi, Nobuaki
    Miyazawa, Naoki
    Nishikawa, Masanori
    Kaneko, Takeshi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 486 - 494
  • [10] Anlotinib combined with radiotherapy in locally advanced non-small cell lung cancer (LANSCLC): A prospective, single-arm, phase II study
    Ning, P.
    Chang, H.
    Zhang, J.
    Rong, P.
    Liu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S944
12345